Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis
Journal of Viral Hepatitis · 2025-08 · 32 (8)
DOI: 10.1111/jvh.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 03.07.2025. Verfasst von Vicki Wing-Ki Hui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Data Analytics Centre (MDAC), Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Liver Cirrhosis, Hepatitis B, Chronic, Alcohol Drinking. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection is a major contributor to cirrhosis, hepatic events and mortality, even when antiviral treatments are used. However, alcohol consumption may compromise these benefits. This study evaluated the impact of alcohol use on outcomes in patients with HBV‐related cirrhosis. Patients initiating first‐line antiviral therapy between 2017 and 2023 were classified as alcohol users (including social drinkers, ex‐drinkers or those with alcohol use disorders) or non‐drinkers, with further differentiation between heavy and mild drinkers. A Fine‐Grey model was used to adjust for the competing risks of non‐liver–related death and liver transplantation, and propensity score matching and weighting balanced baseline characteristics. Among 12,317 patients (mean age 65 years, 77% male), 31% were alcohol users, of whom 32% were heavy drinkers. In propensity score–matched analyses, non‐drinkers exhibited better transplant‐free survival and lower liver‐related mortality than drinkers. Overall, alcohol use was associated with a 20%–30% increased risk of all‐cause mortality or liver transplantation, as well as liver‐related death, with heavy alcohol consumption conferring even greater risk. These findings underscore the need for systematic screening for alcohol consumption and the implementation of interventions aimed at reducing alcohol use in patients with HBV‐related cirrhosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Data Analytics Centre (MDAC), Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
- State Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.
- Gastroenterology and Hepatology Section, Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
ORCID-Profile: Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Robert John Wong
Zitieren
APA
Hui, V. W., Yang, Z., Yip, T. C., Cheung, R., Lai, J. C., Wong, V. W., Wong, G. L., & Wong, R. J. (2025). Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis. Journal of Viral Hepatitis, 32(8). https://doi.org/10.1111/jvh.70049
Vancouver
Hui VW, Yang Z, Yip TC, Cheung R, Lai JC, Wong VW, et al. Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis. Journal of Viral Hepatitis. 2025;32(8). doi:10.1111/jvh.70049
BibTeX
@article{Hui2025,
author = {Hui, Vicki Wing-Ki and Yang, Zeyuan and Yip, Terry Cheuk-Fung and Cheung, Ramsey and Lai, Jimmy Che-To and Wong, Vincent Wai-Sun and Wong, Grace Lai-Hung and Wong, Robert John},
title = {Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis},
journal = {Journal of Viral Hepatitis},
year = {2025},
volume = {32},
number = {8},
doi = {10.1111/jvh.70049}
}
EUVIMED